Table 6 Associations between metabolic traits and MAFLD-HCC in patients without high FIB-4 on univariate and multivariate logistic regression analysis.

From: Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma

Characteristic

Crude OR (95% CI)

p

Adjusted OR (95% CI)

P

Waist circumference

1.00 (0.98–1.01)

0.593

–

–

CRP > 2 mg/L

3.75 (1.64–8.57)

0.002

3.36 (1.32–8.57)

0.011

Prediabetes or Type II diabetes

2.73 (1.59–4.72)

 < 0.001

3.11 (1.66–5.85)

 < 0.001

BMI ≥ 23 kg/m2

3.96 (2.11–7.42)

 < 0.001

4.24 (2.08–8.63)

 < 0.001

Hypertension

2.65 (1.54–4.58)

 < 0.001

2.99 (1.58–5.65)

0.001

Dyslipidemia

2.93 (1.67–5.14)

 < 0.001

3.01 (1.59–5.69)

0.001

  1. FIB-4 fibrosis-4, BMI body mass index.
Back to article page